ID

20442

Descrição

Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01196455

Link

https://clinicaltrials.gov/show/NCT01196455

Palavras-chave

Versões (1)
  1. 22/02/2017 22/02/2017 -
Transferido a

22 de fevereiro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Breast Cancer NCT01196455

Inglês

Eligibility Breast Cancer NCT01196455

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically/cytologically confirmed breast cancer
Descrição

histologically/cytologically confirmed breast cancer

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0332141
UMLS CUI [1,3]
C0679557
metastatic breast cancer, having at least one target lesion according to the recist criteria. bone metastases, leptomeningeal disease, ascites, pleural or pericardial effusions, inflammatory breast disease, lymphangitic spread or cystic lesions are not acceptable as target lesions. target lesions must be ≥ 10 mm longest diameter measured in one dimension using spiral ct, or ≥ 20 mm longest diameter measured in one dimension using conventional techniques. in addition to the definitions pertaining to the target lesion(s) from the recist criteria above, the target lesion(s) must not have been previously irradiated (newly arising lesions in previously irradiated areas are acceptable).
Descrição

Metastatic Neoplasm; Breast Carcinoma; Target Lesion Identification | Secondary malignant neoplasm of bone | Leptomeningeal disease | Ascites | Pericardial effusion | Pleural effusion disorder | Inflammatory disorder of breast | Lymphangitic spread | Cystic Lesion | Conventional manometry | Tomography, Spiral Computed | prior radiation therapy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2939420
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C2986546
UMLS CUI [2]
C0153690
UMLS CUI [3]
C3160796
UMLS CUI [4]
C0003962
UMLS CUI [5]
C0031039
UMLS CUI [6]
C0032227
UMLS CUI [7]
C3495439
UMLS CUI [8]
C3697833
UMLS CUI [9]
C1511606
UMLS CUI [10]
C0441679
UMLS CUI [11]
C0860888
UMLS CUI [12]
C0279134
age > 18 years
Descrição

age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
signed informed consent obtained prior to initiation of any study-specific procedures or treatment
Descrição

informed consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior cytotoxic chemotherapy or active/passive immunotherapy for metastatic breast disease
Descrição

prior cytotoxic chemotherapy or active/passive immunotherapy for metastatic breast disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0021083
UMLS CUI [3,1]
C2939420
UMLS CUI [3,2]
C0678222
prior usage of capecitabine or mitomycin as adjuvant or neoadjuvant treatment
Descrição

prior usage of capecitabine or mitomycin as adjuvant or neoadjuvant treatment

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0671970
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0002475
UMLS CUI [3]
C0600558
UMLS CUI [4]
C0677850
life expectancy < 3 months
Descrição

life expectancy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0023671
not-ambulatory or with an ecog performance status > 1
Descrição

ECOG performance status | Ambulatory Status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C1550332
insufficient hematological, renal and hepatic functions:
Descrição

Renal function | Liver function | Hematologic function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0221130
hemoglobin < 8.0 g/dl
Descrição

hemoglobin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019046
absolute neutrophils count (anc) < 1.5 x 109/l
Descrição

anc

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0948762
platelet count < 100 x 109/l
Descrição

platelet count

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032181
serum creatinine > 1.25 x n*
Descrição

creatinine

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201976
total bilirubin > 2.0 x n*
Descrição

bilirubin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1278039
asat and/or alat > 2.5 x n* (in case of liver metastases > 5 x n*)
Descrição

asat, alat

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
alkaline phosphatase > 2.5 x n* (in case of liver metastases > 5 x n*, in case of bone metastases > 10 x n*) *n = upper limit of standard range
Descrição

alkaline phosphatase

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0201850
severe renal impairment [creatinine clearance < 30 ml/min (calculated according to cockcroft and gault)]
Descrição

creatinine clearance, renal function

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0373595
UMLS CUI [1,2]
C0232804
Voltar ao início da página

Similar models

Eligibility Breast Cancer NCT01196455

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
histologically/cytologically confirmed breast cancer
Item
histologically/cytologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0332141 (UMLS CUI [1,2])
C0679557 (UMLS CUI [1,3])
Metastatic Neoplasm; Breast Carcinoma; Target Lesion Identification | Secondary malignant neoplasm of bone | Leptomeningeal disease | Ascites | Pericardial effusion | Pleural effusion disorder | Inflammatory disorder of breast | Lymphangitic spread | Cystic Lesion | Conventional manometry | Tomography, Spiral Computed | prior radiation therapy
Item
metastatic breast cancer, having at least one target lesion according to the recist criteria. bone metastases, leptomeningeal disease, ascites, pleural or pericardial effusions, inflammatory breast disease, lymphangitic spread or cystic lesions are not acceptable as target lesions. target lesions must be ≥ 10 mm longest diameter measured in one dimension using spiral ct, or ≥ 20 mm longest diameter measured in one dimension using conventional techniques. in addition to the definitions pertaining to the target lesion(s) from the recist criteria above, the target lesion(s) must not have been previously irradiated (newly arising lesions in previously irradiated areas are acceptable).
boolean
C2939420 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C2986546 (UMLS CUI [1,3])
C0153690 (UMLS CUI [2])
C3160796 (UMLS CUI [3])
C0003962 (UMLS CUI [4])
C0031039 (UMLS CUI [5])
C0032227 (UMLS CUI [6])
C3495439 (UMLS CUI [7])
C3697833 (UMLS CUI [8])
C1511606 (UMLS CUI [9])
C0441679 (UMLS CUI [10])
C0860888 (UMLS CUI [11])
C0279134 (UMLS CUI [12])
age
Item
age > 18 years
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
signed informed consent obtained prior to initiation of any study-specific procedures or treatment
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
prior cytotoxic chemotherapy or active/passive immunotherapy for metastatic breast disease
Item
prior cytotoxic chemotherapy or active/passive immunotherapy for metastatic breast disease
boolean
C1514457 (UMLS CUI [1])
C1514463 (UMLS CUI [2,1])
C0021083 (UMLS CUI [2,2])
C2939420 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
prior usage of capecitabine or mitomycin as adjuvant or neoadjuvant treatment
Item
prior usage of capecitabine or mitomycin as adjuvant or neoadjuvant treatment
boolean
C1514463 (UMLS CUI [1,1])
C0671970 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0002475 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3])
C0677850 (UMLS CUI [4])
life expectancy
Item
life expectancy < 3 months
boolean
C0023671 (UMLS CUI [1])
ECOG performance status | Ambulatory Status
Item
not-ambulatory or with an ecog performance status > 1
boolean
C1520224 (UMLS CUI [1])
C1550332 (UMLS CUI [2])
Renal function | Liver function | Hematologic function
Item
insufficient hematological, renal and hepatic functions:
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0221130 (UMLS CUI [3])
hemoglobin
Item
hemoglobin < 8.0 g/dl
boolean
C0019046 (UMLS CUI [1])
anc
Item
absolute neutrophils count (anc) < 1.5 x 109/l
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count < 100 x 109/l
boolean
C0032181 (UMLS CUI [1])
creatinine
Item
serum creatinine > 1.25 x n*
boolean
C0201976 (UMLS CUI [1])
bilirubin
Item
total bilirubin > 2.0 x n*
boolean
C1278039 (UMLS CUI [1])
asat, alat
Item
asat and/or alat > 2.5 x n* (in case of liver metastases > 5 x n*)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
alkaline phosphatase
Item
alkaline phosphatase > 2.5 x n* (in case of liver metastases > 5 x n*, in case of bone metastases > 10 x n*) *n = upper limit of standard range
boolean
C0201850 (UMLS CUI [1])
creatinine clearance, renal function
Item
severe renal impairment [creatinine clearance < 30 ml/min (calculated according to cockcroft and gault)]
boolean
C0373595 (UMLS CUI [1,1])
C0232804 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial